How Drug Prices Work | WSJ
The Wall Street Journal・2 minutes read
The pricing of pharmaceutical drugs involves a complex system of rebates negotiated between drug companies and pharmacy benefit managers, impacting patient copays and overall drug sales. Patients often pay based on list prices rather than post-rebate costs due to the intricate nature of drug pricing among different entities, leading to confusion and complexity in the pricing process for consumers.
Insights
- Pharmaceutical companies use rebates to negotiate with PBMs, impacting drug placement and pricing for patients, leading to discrepancies between list prices and actual costs for consumers.
- The drug pricing system involves a multi-layered process with various entities like drug makers, insurance companies, and PBMs, showcasing the complexity of pricing structures for different products, such as prescription drugs compared to beverages like Pepsi.
Get key ideas from YouTube videos. It’s free
Recent questions
How do pharmaceutical companies determine drug prices?
Pharmaceutical companies set list prices for drugs based on various factors such as production costs, research and development expenses, market demand, and competition. These list prices serve as the starting point for negotiations with other entities in the supply chain.
What role do rebates play in drug pricing?
Rebates are a crucial aspect of drug pricing, with pharmaceutical companies offering them to pharmacy benefit managers (PBMs) in exchange for better placement on formularies. These rebates help lower costs for employers and insurance companies, influencing patient copays and overall drug sales.
How do patients pay for prescription drugs?
Patients typically pay copays for prescription drugs, which are often based on list prices set by pharmaceutical companies. Despite the existence of rebates negotiated by PBMs, patients may not always benefit from the lower post-rebate costs due to the complexities of drug pricing.
Who negotiates rebates with pharmaceutical companies?
Pharmacy benefit managers (PBMs) are responsible for negotiating rebates with pharmaceutical companies to lower costs for employers and insurance companies. These negotiations play a significant role in determining the final prices that patients pay for prescription drugs.
Why is drug pricing so complex for consumers?
Drug pricing is complex for consumers due to the involvement of multiple entities like pharmaceutical companies, wholesalers, PBMs, and insurance companies. The intricacies of rebates, list prices, and negotiations among these entities contribute to the confusion surrounding drug pricing, making it challenging for patients to understand the true costs of their medications.
Related videos
The Young Turks
Big Pharma: We're Going To Sue Medicare Over Price Regulations
CNBC
Why Pharmaceuticals Are So Complicated In The U.S. | CNBC Marathon
DW Documentary
Big Pharma - How much power do drug companies have? | DW Documentary
More Perfect Union
The Covert Legal Strategy to Keep Your Drug Prices High
Vox
Why drugs cost more in America
Summary
00:00
Complex Drug Pricing: Rebates, List Prices, Entities
- The pricing process for products varies; while a beverage like Pepsi follows a simple supply chain, prescription drugs involve a complex pricing system involving various entities like drug makers, insurance companies, and pharmacy benefit managers.
- Pharmaceutical companies set list prices for drugs, wholesalers transport them to pharmacies, patients pay copays, and pharmacy benefit managers negotiate rebates with drug companies to lower costs for employers and insurance companies.
- Rebates play a significant role in drug pricing, with pharmaceutical companies offering them to PBMs to secure better placement on formularies, influencing patient copays and drug sales.
- Patients often pay based on list prices rather than post-rebate costs, with the intricacies of rebates and pricing differences among entities contributing to the complexity of drug pricing for consumers.
